Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
370.5 SEK | -2.24% | +15.42% | +12.44% |
24/04 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
24/04 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Business Summary
Number of employees: 148
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Thoracic
64.3
%
| 296 | 71.4 % | 384 | 64.3 % | +29.70% |
Abdominal
22.4
%
| 71 | 17.1 % | 134 | 22.4 % | +89.16% |
Services
13.2
%
| 48 | 11.6 % | 79 | 13.2 % | +64.61% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
51.6
%
| 225 | 54.1 % | 308 | 51.6 % | +37.01% |
EMEA Excluding Sweden, Netherlands and Italy
21.5
%
| 97 | 23.4 % | 128 | 21.5 % | +32.27% |
Italy
9.9
%
| 21 | 5.2 % | 59 | 9.9 % | +174.32% |
Asia/Pacific and Oceania
7.1
%
| 19 | 4.5 % | 42 | 7.1 % | +124.24% |
Netherlands
5.1
%
| 26 | 6.3 % | 30 | 5.1 % | +16.29% |
North and South America, Excluding the United States
4.3
%
| 25 | 6.1 % | 26 | 4.3 % | +0.53% |
Sweden
0.7
%
| 2 | 0.4 % | 4 | 0.7 % | +152.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 01/12/01 | |
Director of Finance/CFO | 39 | - | |
Chief Tech/Sci/R&D Officer | 57 | 01/20/01 | |
Chief Tech/Sci/R&D Officer | 47 | 23/20/23 | |
Lena Hagman
COO | Chief Operating Officer | 59 | 01/22/01 |
Jaya Tiwari
PRN | Corporate Officer/Principal | 37 | 22/21/22 |
Johan Holmström
PRN | Corporate Officer/Principal | 54 | 07/20/07 |
Corporate Officer/Principal | - | 23/20/23 | |
Henrik Isaksson
PRN | Corporate Officer/Principal | 53 | 01/18/01 |
Fredrik Dalborg
PRN | Corporate Officer/Principal | 52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Camilla Öberg
BRD | Director/Board Member | 60 | 01/16/01 |
Chairman | 65 | - | |
Lars Henrikson
BRD | Director/Board Member | 69 | 01/20/01 |
Erik Strömqvist
BRD | Director/Board Member | 54 | - |
Lena Höglund
BRD | Director/Board Member | 64 | 01/20/01 |
Goran Dellgren
BRD | Director/Board Member | 63 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,499,470 | 23,664,795 ( 75.13 %) | 0 | 75.13 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.44% | 1.09B | |
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 67.52B | |
+2.06% | 50.06B | |
+9.43% | 45.67B | |
+3.40% | 41B | |
+3.04% | 26.73B | |
+4.64% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- XVIVO Stock
- Company Xvivo Perfusion AB